[1]Harvold, Egil. Cleft Palate, An Experiment[J]. Acta Odontologica Scandinavica, 1950, 9(1):84-87.
[2]Chierici G , Harvold E P , Dawson W J . Primate Experiments on Facial Asymmetry[J]. Journal of Dental Research, 1970, 49(4):847-851.
[3]Longaker M T , Stern M , Lorenz H P , et al. A Model for Fetal Cleft Lip Repair in Lambs[J]. Plastic and Reconstructive Surgery, 1992, 90(5):750-756.
[4]Weinberg M A , Bral M . Laboratory animal models in periodontology[J]. Journal Of Clinical Periodontology, 1999, 26(6):335-340.
[5]Liao L S , Tan Z , Zheng Q , et al. Animal experimental study on repairing alveolar clefts by using rectilinear distraction osteogenesis[J]. Journal of Plastic Reconstructive & Aesthetic Surgery, 2009, 62(12):1573-1579.
[6]Dalia E B , Smith S J , Germane N , et al. New Technique for Creating Permanent Experimental Alveolar Clefts in a Rabbit Model[J]. The Cleft Palate-Craniofacial Journal, 1993, 30(6):542-547.
[7]Bardach J , Kelly K M . Role of Animal Models in Experimental Studies of Craniofacial Growth Following Cleft Lip and Palate Repair[J]. The Cleft palate journal, 1988, 25(2):103-113.
[8]Xue-Cheng Sun,Ze-Biao Zhang et al. Comparison of three surgical models of bone tissue defects in cleft palate in rabbits[J]. International Journal of Pediatric Otorhinolaryngology.2019(124):164-172.
[9]Binger T , Katsaros C , Martin Rücker, et al. Segment Distraction to Reduce a Wide Alveolar Cleft Before Alveolar Bone Grafting[J]. The Cleft Palate-Craniofacial Journal, 2003, 40(6):561-565.
[10]Boyne P J . Secondary bone grafting of residual alveolar and palatal clefts[ J] .J Oral Surg, 1972, 30( 2) :87-92.
[11]Cohen M , Figueroa A A , Haviv Y , et al. Iliac Versus Cranial Bone for Secondary Grafting of Residual Alveolar Clefts[J]. Plastic and Reconstructive Surgery, 1991, 87(3):423-427.
[12]Tai C C E , Sutherland I S , Mcfadden L . Prospective analysis of secondary alveolar bone grafting using computed tomography [J]. Journal of Oral & Maxillofacial Surgery Official Journal of the American Association of Oral & Maxillofacial Surgeons, 2000, 58(11):1241-1249.
[13]Nique T , Fonseca R J , Upton L G , et al. Particulate allogeneic bone grafts into maxillary alveolar clefts in humans: A preliminary report[J]. Journal of Oral and Maxillofacial Surgery, 1987, 45(5):386-392.
[14]El Deeb M , Tompach P C , Morstad A T , et al. Long-term follow-up of the use of nonporous hydroxyapatite for augmentation of the alveolar ridge[J]. Journal of oral and maxillofacial surgery: official journal of the American Association of Oral and Maxillofacial Surgeons,1991,49(3):257-261.
[15]Chan B P , Hui T Y , Wong M Y , et al. Mesenchymal Stem Cell–Encapsulated Collagen Microspheres for Bone Tissue Engineering[J]. TISSUE ENGINEERING PART C-METHODS, 2010, 16(2):225-235.
[16]Johnson K D, Frierson K E, Keller T S , et al. Porous ceramics as bone graft substitutes in long bone defects: A biomechanical, histological, and radiographic analysis[J]. Journal of Orthopaedic Research, 1996, 14(3):351-369.
[17]Shuai C, Zhou J, Wu P, et al. Enhanced Stability of Calcium Sulfate Scaffolds with 45S5Biologlass for Bone Repair [J]. Materials,2015, 8(11):7498-7510.
[18] Smith BT,Santoro M,Grosfeld EC,et al. Incorporation of fast dissolving glucose porogens into an injectable calcium phosphate cement for bone tissue engineering [J]. ActaBiomaterialia,2016,50(Mar 1):68-77.
[19]Rahaman MN, Day DE, Bal BS, et al. Bioactive glass in tissue engineering. ActaBiomater, 2011, 7(6): 2355-2373.
[20]Hibi H , Yamada Y , Ueda M , et al. Alveolar cleft osteoplasty using tissue-engineered osteogenic material[J]. International Journal of Oral & Maxillofacial Surgery, 2006, 35(6):551-555.
[21]Liu S , Hou K D , Yuan M , et al. Characteristics of mesenchymal stem cells derived from Wharton's jelly of human umbilical cord and for fabrication of non-scaffold tissue-engineered cartilage[J]. Journal of Bioscience & Bioengineering, 2014, 117(2):229-235.
[22]Jin YZ, Lee JH. Mesenchymal stem cell therapy for bone regeneration. Clin. Orthop. Surg. 10(3), 271–278 (2018).
[23]Tassi S A , Sergio N Z , Misawa M Y O , et al. Efficacy of stem cells on periodontal regeneration: Systematic review of pre-clinical studies[J]. Journal of Periodontal Research, 2017, 52(5): 793-812.
[24] Li X, Tan J, Xiao Z et al. Transplantation of hUC-MSCs seeded collagen scaffolds reduces scar formation and promotes functional recovery in canines with chronic spinal cord injury. Sci. Rep. 7, 43559 (2017).
[25]Campisi P, Handy RC, et al. Expressing of bone morphogenetic protein during mandibular distraction osteogenesis[J]. Plast Reconstr Surg,2003;111:201-208.
[26] Wang Limin, Tran I, Seshareddy K, et al. A comparison of human bone marrow-derived mesenchymal stem cells and human umbilical cord-derived mesenchymal stromal cells for cartilage tissue engineering [J]. Tissue Eng A, 2009,15(8):2259-2266.
[27] Liu LS, Thompson AY, Heidaran MA, Poser JW, Spiro RC. An osteoconductive collagen/ hyaluronate matrix for bone regeneration. Biomaterials 1999;20(12):1097–108.
[28] Hollinger JO, Schmitt JM, Buck DC, Shannon R, Joh SP, Zegzula HD, et al. Recombinant human bone morphogenetic protein-2 and collagen for bone regeneration. J Biomed Mater Res 1998;43(4):356–64.
[29] Böer U, Lohrenz A, Klingenberg M, et al. The eff ect of detergent-based decellularization procedures on cellular proteins and immunogenicity in equine carotid artery grafts. Biomaterials, 2011, 32(36): 9730-9737.
[30]Song K, Yang Y, Xu L et al. Fabrication and detection of tissue engineered bone aggregates based on encapsulated human ADSCs within hybrid calcium alginate/bone powder gel-beads in a spinner flask. Mater. Sci. Eng. C Mater. Biol. Appl. 62, 787–794 (2016).
[31]Wang N, Xiao Z, Zhao Y et al. Collagen scaffold combined with human umbilical cord-derived mesenchymal stem cells promote functional recovery after scar resection in rats with chronic spinal cord injury. J. Tissue. Eng. Regen. Med. 12(2), e1154–e1163 (2018).
[32] Shin M, Yoshimoto H, Vacanti JP. In vivo bone tissue engineering using mesenchymal stem cells on a novel electrospun nanofibrous scaffold. Tissue Eng 2004;10(1–2):33–41.
[33] Mooiweer E,Luijik B,Bonten MJ,etal. C-reactive protein levels but not CRP dynamics predict mortality in patients with pneumococal pneumonia[J].J Infect, 2011, 62 (4):313-316.
[34] Cosman F,Nieves J,Zion M,et al. Daily and cyclic parathyroid hormone in women receiving alendronate[J].NEngl J Med,2005,353(6):566⁃575.
[35] Han P, Cheng P, Zhang S, et al. In vitro and in vivo studies on the degradation of high-purity Mg (99.99wt.% ) screw with femoral intracondylar fractured rabbit model[J]. Biomaterials, 2015, 64: 57-69
[36] Sotoudehbagha P, Sheibani S, Khakbiz M, et al. Novel antibacterial biodegradable Fe-Mn-Ag alloys produced by mechanical alloying[J]. Mater Sci Eng C Mater Biol Appl, 2018, 88: 88-94
[37] Mostaed E, Sikora-Jasinska M, Drelich J W, et al. Zinc-based alloys for degradable vascular stent applications [J]. Acta Biomater, 2018, 71: 1-23
[38] Cramer JA,Gold DT,Silverman SL,et al. A systematic review of persistence and compliance with bisphosphonates for osteoporosis. Osteoporos Int.2007;18(8):1023-1031.
[39] zur Nieden NI, Kempka G, Ahr HJ. In vitro differentiation of embryonic stem cells into mineralized osteoblasts. Differentia-tion 2003;71:18-27.